First reported case of lysinuric protein intolerance (LPI) in Lithuania, confirmed biochemically and by DNA analysis

[1]  O. Simell,et al.  Two alternative promoters regulate the expression of lysinuric protein intolerance gene SLC7A7. , 2007, Molecular genetics and metabolism.

[2]  O. Simell,et al.  Long-term oral lysine supplementation in lysinuric protein intolerance. , 2007, Metabolism: clinical and experimental.

[3]  M. P. Sperandeo,et al.  Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene , 2005, Human mutation.

[4]  R. Carrozzo,et al.  Increased NO production in lysinuric protein intolerance , 2005, Journal of Inherited Metabolic Disease.

[5]  O. Simell,et al.  Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance. , 2003, Metabolism: clinical and experimental.

[6]  K. Ihara,et al.  Five novel SLC7A7 variants and y+L gene‐expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intolerance , 2002, Human Mutation.

[7]  G. Borsani,et al.  The molecular bases of cystinuria and lysinuric protein intolerance. , 2001, Current opinion in genetics & development.

[8]  G. Borsani,et al.  Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance. , 2000, American journal of human genetics.

[9]  D. Torrents,et al.  Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene , 1999, Nature Genetics.

[10]  G. Borsani,et al.  SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance , 1999, Nature Genetics.

[11]  M. Nagao,et al.  [Lysinuric protein intolerance and other cationic aminoacidurias]. , 1998, Ryoikibetsu shokogun shirizu.

[12]  O. Simell,et al.  Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14. , 1997, American journal of human genetics.

[13]  G. Andria,et al.  Early detection of lung involvement in lysinuric protein intolerance: role of high-resolution computed tomography and radioisotopic methods. , 1996, American journal of respiratory and critical care medicine.

[14]  G. Andria,et al.  Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical course. , 1995, The Journal of pediatrics.

[15]  T. Kato,et al.  Hyperammonemia in lysinuric protein intolerance. , 1984, Pediatrics.

[16]  O. Simell,et al.  Oral administration of ∈N-acetyllysine and homocitrulline in lysinuric protein intolerance , 1983 .

[17]  O. Simell,et al.  Lysinuric protein intolerance. Basolateral transport defect in renal tubuli. , 1981, The Journal of clinical investigation.

[18]  O. Simell,et al.  BASOLATERAL-MEMBRANE TRANSPORT DEFECT FOR LYSINE IN LYSINURIC PROTEIN INTOLERANCE , 1980, The Lancet.

[19]  J. Perheentupa,et al.  Lysine fluxes across the jejunal epithelium in lysinuric protein intolerance. , 1980, The Journal of clinical investigation.

[20]  J. Perheentupa,et al.  Lysinuric protein intolerance, an autosomal recessive disease , 1971, Clinical genetics.

[21]  J. Perheentupa,et al.  Protein intolerance with deficient transport of basic aminoacids. Another inborn error of metabolism. , 1965, Lancet.